These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8866709)

  • 1. Cholinergic improvement of a naturally-occurring memory deficit in the young rat.
    Smith RD; Kistler MK; Cohen-Williams M; Coffin VL
    Brain Res; 1996 Jan; 707(1):13-21. PubMed ID: 8866709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of tropicamide on mydriasis in young rats exhibiting a natural deficit in passive-avoidance responding.
    Smith RD; Grzelak ME; Belanger B; Morgan CA
    Life Sci; 1996; 59(9):753-60. PubMed ID: 8761028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1991 Sep; 56(2):183-99. PubMed ID: 1759940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraining infusion of cholinergic drugs into the ventral subiculum modulated memory in an inhibitory avoidance task: interaction with the bed nucleus of the stria terminalis.
    Liu TL; Liang KC
    Neurobiol Learn Mem; 2009 Mar; 91(3):235-42. PubMed ID: 19041726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic nicotine effects on working memory in aged rats.
    Levin ED; Torry D
    Psychopharmacology (Berl); 1996 Jan; 123(1):88-97. PubMed ID: 8741959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Dennes RP; Barnes JC
    Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Salvia officinalis L. (sage) leaves on memory retention and its interaction with the cholinergic system in rats.
    Eidi M; Eidi A; Bahar M
    Nutrition; 2006 Mar; 22(3):321-6. PubMed ID: 16500558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraseptal infusion of oxotremorine impairs memory in a delayed-non-match-to-sample radial maze task.
    Bunce JG; Sabolek HR; Chrobak JJ
    Neuroscience; 2003; 121(2):259-67. PubMed ID: 14521985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic modulation of memory in rats.
    Haroutunian V; Barnes E; Davis KL
    Psychopharmacology (Berl); 1985; 87(3):266-71. PubMed ID: 3001803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxotremorine on inhibitory avoidance behaviour in two inbred strains of mice: interaction with 5-methoxy-NN-dimethyltriptamine.
    Pavone F; Fagioli S; Castellano C
    Psychopharmacology (Berl); 1993; 112(2-3):249-52. PubMed ID: 7871027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
    Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex.
    Jones CK; Shannon HE
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1017-23. PubMed ID: 10945854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats.
    Chopin P; Briley M
    Psychopharmacology (Berl); 1992; 106(1):26-30. PubMed ID: 1738791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic effects on spatial exploration and its memory.
    Kelly PH; Malanowski J
    Can J Physiol Pharmacol; 1993; 71(5-6):352-64. PubMed ID: 8402401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.